The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Fri., Apr. 29, 11:48 AM

Slide #5. Ignyta, Inc Secondary Offering

Company: Ignyta, Inc (NASDAQ:RXDX)
Date announced: 4/27/2016
Secondary Offering Details: Ignyta, Inc. (NASDAQ:RXDX) ("Ignyta"), a precision oncology biotechnology company, today announced that it has commenced an underwritten public offering to sell approximately $50.0 million of shares of its common stock. In connection with this offering, Ignyta expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering at the public offering price, less the underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Ignyta is a biotechnology company targeting new drugs for cancer patients whose tumors harbor specific molecular alterations. Co. is pursuing an integrated drug and diagnostic, pairing each of its product candidates with biomarker-based companion diagnostics developed by Co. or third parties. Co.'s plans focus on two product candidates: entrectinib, a tyrosine kinase inhibitor directed to the Trk family tyrosine kinase receptors (TrkA, TrkB and TrkC), ROS1 and ALK proteins, which is in Phase I/II clinical studies in molecularly defined patient populations for the treatment of solid tumors; and RXDX-103, a development program targeting the cell division cycle 7-related protein kinase.

RXDX SEC Filing Email Alerts Service

Open the RXDX Page at The Online Investor »

Company Name:  Ignyta Inc
Sector:  Biotechnology
Number of ETFs Holding RXDX:  15
Total Market Value Held by ETFs:  $3.61M
Total Market Capitalization:  $244.00M
% of Market Cap. Held by ETFs:  1.48%

Open the RXDX Page at The Online Investor (in a new window) »

April 29, 2016    11:48 AM Eastern
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
84th percentile
(ranked higher than approx. 84% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.